Kelman Lazarov Inc. Has $1.38 Million Position in Clorox Company (The) (NYSE:CLX)

Kelman Lazarov Inc. cut its stake in Clorox Company (The) (NYSE:CLX) by 4.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,375 shares of the company’s stock after selling 435 shares during the period. Kelman Lazarov Inc.’s holdings in Clorox Company (The) were worth $1,382,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. American Beacon Advisors Inc. bought a new position in shares of Clorox Company (The) during the first quarter valued at approximately $104,000. Quadrant Capital Group LLC raised its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares in the last quarter. Valley National Advisers Inc. raised its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. raised its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. Finally, Zions Bancorporation raised its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares in the last quarter. Hedge funds and other institutional investors own 69.83% of the company’s stock.

Clorox Company (NYSE:CLX) opened at 137.73 on Friday. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The company has a 50 day moving average of $133.55 and a 200-day moving average of $134.12. The stock has a market capitalization of $17.78 billion, a P/E ratio of 25.82 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the prior year, the company earned $1.30 EPS. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. Equities research analysts anticipate that Clorox Company will post $5.67 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/08/19/kelman-lazarov-inc-decreases-stake-in-clorox-company-the-nyseclx-updated-updated.html.

A number of equities research analysts have issued reports on CLX shares. UBS AG reiterated a “sell” rating and set a $121.00 target price (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Finally, Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit